Applied BioCode Corporation (6598.TW) TAI
24.30
+0.1(+0.41%)
Currency In TWD
- General
- Statistics
- Historical Data
- Profile
- Financials
Valuation
| Market Cap | 2.26B |
| Enterprise Value | 1.85B |
| P/E Ratio | -17.64 |
| PEG Ratio | -0.34 |
| Price/Sales Ratio | 4.37 |
| Price/Book Ratio | 3.77 |
| Enterprise/Revenue | 3.7 |
| Enterprise/EBITDA | -12.4 |
Fiscal Year
| Fiscal Year | December 31, 2025 |
| Most Recent Quarter | March 31, 2026 |
Profitability
| Profit Margin | -0.25 |
| Operating Margin | -0.28 |
Management Effectiveness
| Return On Assets | -0.13 |
| Return On Equity | -0.21 |
Income Statement
| Revenue | 475.2M |
| Revenue/Share | 5.46 |
| Gross Profit | 260.89M |
| EBITDA | -166.96M |
| Net Income | -201.2M |
| Diluted EPS | -1.96 |
Balance Sheet
| Total Cash | 542.48M |
| Total Cash/Share | 5.17 |
| Total Debt | 55.83M |
| Total Debt/Equity | 0.08 |
| Current Ratio | 6.02 |
| Book Value Per Share | 6.44 |
Price History
| 52-Week Change | 6.11 |
| 52-Week High | 26 |
| 52-Week Low | 18.85 |
| Moving Average 50 Days | 23.27 |
| Moving Average 200 Days | 22.81 |
Statistics
| Average Volume | 181,880 |
| Shares Outstanding | 102.82M |
| % Held by Institutions | N/A |
Dividend And Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0 |
| Payout Ratio | 0 |
| Last Split Factor | 529:500 |
| Last Split Date | July 02, 2024 |
